BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 172 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,890,743 | -81.3% | 408,297 | -66.6% | 0.01% | -87.2% |
| Q3 2022 | $15,419,000 | +22.0% | 1,223,721 | +2.4% | 0.05% | +14.6% |
| Q2 2022 | $12,638,000 | +61.8% | 1,194,511 | -69.4% | 0.04% | -55.4% |
| Q1 2020 | $7,811,000 | +14364.8% | 3,905,676 | +35114.8% | 0.09% | – |
| Q4 2017 | $54,000 | -80.9% | 11,091 | -79.4% | 0.00% | -100.0% |
| Q3 2017 | $282,000 | -78.3% | 53,796 | -38.2% | 0.00% | -87.5% |
| Q2 2015 | $1,301,000 | – | 87,111 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |